KRYSTEXXA®
Administration of LEMTRADA® is intravenously infused over 4 hours for a 2 or more treatment course. First course consists of 12mg/ day for 5 consecutive days followed by 12mg/day on 3 consecutive days 12 months after the first course.
Administration and Dosage:
Administration of KRYSTEXXA® is by a bi-weekly intravenous infusion.
Common Side Effects:
The more common side effects of LEMTRADA® include serious autoimmune problems, serious infusion reactions, certain cancers, and stroke and tears in your arteries that supply blood to your brain (carotid and vertebral arteries).
More information:
Please read the full Prescribing Information and Medication Guide for LEMTRADA® and discuss any questions you have with your doctor.
Indication:
Lemtrada® is indicated to treat:
Forms of Relapsing Multiple Sclerosis
Contact Us
Interested in working together? Fill out some info and we will be in touch shortly. We can’t wait to hear from you!
Check our Privacy Practice